Moreover, rescue experiments using SC79, an AKT agonist,38 partially restored the proliferative and migratory abilities of HCC cells by silencing DCTN2, further supporting the involvement of the AKT pathway in DCTN2‐mediated tumour suppression. This evidence concerns the gene AKT1 and neoplasm.